Drug Design, Development and Therapy (Oct 2021)

Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]

  • Shuja SH,
  • Eqbal F,
  • Rehman H

Journal volume & issue
Vol. Volume 15
pp. 4227 – 4228

Abstract

Read online

Syed Hasan Shuja, Farea Eqbal, Hafsa Rehman Dow Medical College, Karachi, Sindh, PakistanCorrespondence: Syed Hasan ShujaDow Medical College, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, 74200, PakistanTel +923200250770Email [email protected] View the original paper by Dr Fraile and colleagues

Keywords